WUXI, China, June 5, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, announced it has successfully launched the GMP operation of its new drug product ...
WuXi Biologics, a CDMO, launched the GMP operation of its new drug product facility DP5 located in Wuxi, China. The DP5 is the ninth operational drug product facility in the global network of WuXi ...
DUBLIN--(BUSINESS WIRE)--"A Practical Overview of Pre-Filled Syringes Training Course (Nov 5th - Nov 6th, 2025)" training has been added to ResearchAndMarkets.com's offering. This course offers a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results